Compugen Ltd (CGEN) shareholders
Close on Nov 17, 2026Market cap $191.00MP/E 5.3Yield –
Ownership
Who owns Compugen's shares
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Eran Ophir | President and CEO, Director | 11,375 | 0.01% | Jul 30, 2026 |
| Pierre Ferre | Chief Operating Officer | – | – | Jul 30, 2026 |
| Michelle Mahler | Chief Medical Officer | 36,625 | 0.04% | Jul 30, 2026 |
| Zurit Levine | SVP, Business Development | 47,375 | 0.05% | Jul 30, 2026 |
| David Silberman | Chief Financial Officer | 55,000 | 0.06% | Jul 30, 2026 |
| Russo Sharon Kredo | SVP, Research & Discovery | 37,500 | 0.04% | Jul 30, 2026 |
| Anat Cohen-Dayag | Director | 108,622 | 0.11% | Jul 30, 2026 |
| Eran Perry | Director | 17,500 | 0.02% | Jul 30, 2026 |
| Mathias Hukkelhoven | Director | 17,500 | 0.02% | Jul 30, 2026 |
| Gilead Halevy | Director | 18,907 | 0.02% | Jul 30, 2026 |
| Savitzky Kinneret Livnat | Director | 20,850 | 0.02% | Jul 30, 2026 |
| Sanford S. Zweifach | Director | 20,180 | 0.02% | Jul 30, 2026 |
| Michele Holcomb | Director | 15,000 | 0.02% | Mar 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Russo Sharon Kredo SVP, Research & Discovery | Jul 29, 2026 | Award | +18,000 | – | – | 37,500 |
| Eran Perry Director | Jul 29, 2026 | Award | +7,500 | – | – | 17,500 |
| David Silberman Chief Financial Officer | Jul 29, 2026 | Award | +19,500 | – | – | 55,000 |
| Mathias Hukkelhoven Director | Jul 29, 2026 | Award | +7,500 | – | – | 17,500 |
| Zurit Levine SVP, Business Development | Jul 29, 2026 | Award | +18,000 | – | – | 47,375 |
| Sanford S. Zweifach Director | Jul 29, 2026 | Award | +7,500 | – | – | 20,180 |
| Michelle Mahler Chief Medical Officer | Jul 29, 2026 | Award | +13,500 | – | – | 36,625 |
| Savitzky Kinneret Livnat Director | Jul 29, 2026 | Award | +7,500 | – | – | 20,850 |
| Gilead Halevy Director | Jul 29, 2026 | Award | +7,500 | – | – | 18,907 |
| Zurit Levine SVP, Business Development | Jul 9, 2026 | Sale(10b5-1 plan) | −1,875 | $2.50 | $4.69K | 29,375 |
| Zurit Levine SVP, Business Development | Jul 9, 2026 | Option exercise | +1,875 | $0.83 | $1.56K | 31,250 |
| Eran Ophir President and CEO, Director | Apr 24, 2026 | Sale(10b5-1 plan) | −5,000 | $3.20 | $16.00K | 11,375 |
| Eran Ophir President and CEO, Director | Apr 24, 2026 | Option exercise | +5,000 | $0.83 | $4.15K | 16,375 |
| Zurit Levine SVP, Business Development | Apr 24, 2026 | Sale(10b5-1 plan) | −2,000 | $3.20 | $6.40K | 29,375 |
| Zurit Levine SVP, Business Development | Apr 24, 2026 | Option exercise | +2,000 | $1.15 | $2.30K | 31,375 |
| Zurit Levine SVP, Business Development | Apr 14, 2026 | Option exercise | +2,000 | $1.15 | $2.30K | 31,375 |
| Zurit Levine SVP, Business Development | Apr 14, 2026 | Sale(10b5-1 plan) | −2,000 | $2.80 | $5.60K | 29,375 |
| Eran Ophir President and CEO, Director | Apr 14, 2026 | Option exercise | +5,000 | $0.83 | $4.15K | 16,375 |
| Eran Ophir President and CEO, Director | Apr 14, 2026 | Sale(10b5-1 plan) | −5,000 | $2.90 | $14.50K | 11,375 |
| Zurit Levine SVP, Business Development | Apr 10, 2026 | Sale(10b5-1 plan) | −3,125 | $2.56 | $8.00K | 29,375 |
| Zurit Levine SVP, Business Development | Apr 10, 2026 | Option exercise | +2,000 | $1.15 | $2.30K | 32,500 |
| Zurit Levine SVP, Business Development | Apr 10, 2026 | Option exercise | +1,125 | $0.83 | $934 | 30,500 |
| Zurit Levine SVP, Business Development | Apr 10, 2026 | Option exercise | +2,000 | $1.15 | $2.30K | 32,500 |
| Zurit Levine SVP, Business Development | Apr 10, 2026 | Option exercise | +1,125 | $0.83 | $934 | 30,500 |
| Zurit Levine SVP, Business Development | Apr 10, 2026 | Sale(10b5-1 plan) | −3,125 | $2.56 | $8.00K | 29,375 |
| Zurit Levine SVP, Business Development | Apr 8, 2026 | Option exercise | +1,000 | $1.15 | $1.15K | 34,750 |
| Zurit Levine SVP, Business Development | Apr 8, 2026 | Option exercise | +4,375 | $0.83 | $3.63K | 33,750 |
| Zurit Levine SVP, Business Development | Apr 8, 2026 | Sale(10b5-1 plan) | −5,375 | $2.42 | $13.01K | 29,375 |
| Zurit Levine SVP, Business Development | Apr 7, 2026 | Sale(10b5-1 plan) | −2,500 | $2.30 | $5.75K | 29,375 |
| Zurit Levine SVP, Business Development | Apr 7, 2026 | Option exercise | +2,500 | $0.83 | $2.08K | 31,875 |
| Zurit Levine SVP, Business Development | Apr 1, 2026 | Option exercise | +1,000 | $1.15 | $1.15K | 32,875 |
| Zurit Levine SVP, Business Development | Apr 1, 2026 | Sale(10b5-1 plan) | −3,500 | $2.20 | $7.70K | 29,375 |
| Zurit Levine SVP, Business Development | Apr 1, 2026 | Option exercise | +2,500 | $0.83 | $2.08K | 31,875 |
| Eran Ophir President and CEO, Director | Apr 1, 2026 | Sale(10b5-1 plan) | −5,625 | $2.21 | $12.43K | 11,375 |
| Eran Ophir President and CEO, Director | Apr 1, 2026 | Option exercise | +5,625 | $0.83 | $4.67K | 17,000 |
| Zurit Levine SVP, Business Development | Mar 26, 2026 | Sale(10b5-1 plan) | −11,875 | $2.04 | $24.23K | 29,375 |
| Zurit Levine SVP, Business Development | Mar 26, 2026 | Option exercise | +11,875 | $0.83 | $9.86K | 41,250 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Compugen's stock actually held short. Settlement fails (shares not delivered on time) peaked at 12,221 shares on Oct 2, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Eran Ophir Officer | Apr 27, 2026 | 5,000 | $14.60K | Apr 24, 2026 | Employee Stock Option Plan |
| Zurit Levine Officer | Apr 27, 2026 | 4,000 | $11.68K | Apr 24, 2026 | Employee Stock Options plan |
| Zurit Levine Officer | Apr 15, 2026 | 2,000 | $5.52K | Apr 14, 2026 | Employee Stock Options plan |
| Eran Ophir Officer | Apr 15, 2026 | 5,000 | $13.80K | Apr 14, 2026 | Employee Stock Option Plan |
| Zurit Levine Officer | Apr 13, 2026 | 2,000 | $4.96K | Apr 10, 2026 | Employee Stock Options plan |
| Eran Ophir Officer | Apr 2, 2026 | 5,625 | $11.98K | Apr 1, 2026 | Employee Stock Options plan |
| Zurit Levine Officer | Mar 26, 2026 | 24,375 | $50.21K | Mar 26, 2026 | Employee Stock Options plan |
See a number that looks wrong?